1bhx

From Proteopedia

(Difference between revisions)
Jump to: navigation, search

OCA (Talk | contribs)
(New page: 200px<br /> <applet load="1bhx" size="450" color="white" frame="true" align="right" spinBox="true" caption="1bhx, resolution 2.30&Aring;" /> '''X-RAY STRUCTURE OF ...)
Next diff →

Revision as of 14:03, 12 November 2007


1bhx, resolution 2.30Å

Drag the structure with the mouse to rotate

X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357

Contents

Overview

We have designed, synthesized, and tested in vitro a novel class of, noncovalent thrombin inhibitors. The main feature of these inhibitors is a, 6,5-fused bicyclic core structure that fills the S2 pocket of the active, site of thrombin. The bicycle introduces conformational constraint into, the ligand and locks the Xaa-Pro amide bond into the desired trans, configuration. Among the known ring systems, we selected by molecular, modeling the 7-thiaindolizidinones (BTD) as our basic template. The, influence of several structural features was analyzed: the length of the, argininal side chain, the stereochemistry at C6, and the importance of, making optimal use of the S3 pocket. Finally, an X-ray crystal structure, of inhibitor 15 bound to thrombin was obtained at a resolution of 2.3 A., These designed thrombin inhibitors, which were prepared by an efficient, synthesis, showed high selectivity over trypsin and other serine, proteases. Further derivation based on the information obtained by X-ray, crystallography should certainly allow to improve the potency.

Disease

Known diseases associated with this structure: Dysprothrombinemia OMIM:[176930], Hyperprothrombinemia OMIM:[176930], Hypoprothrombinemia OMIM:[176930]

About this Structure

1BHX is a Protein complex structure of sequences from Homo sapiens with R56 as ligand. Active as Thrombin, with EC number 3.4.21.5 Full crystallographic information is available from OCA.

Reference

Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors., Wagner J, Kallen J, Ehrhardt C, Evenou JP, Wagner D, J Med Chem. 1998 Sep 10;41(19):3664-74. PMID:9733491

Page seeded by OCA on Mon Nov 12 16:10:06 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools